PharVision Advisers’s TTEC Holdings TTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.4K Sell
14,117
-14,457
-51% -$37.4K 0.52% 62
2026
Q1
$71.4K Buy
+28,574
New +$81.8K 0.72% 71
2025
Q4
Sell
-88,491
Closed -$297K 1011
2025
Q3
$297K Buy
+88,491
New +$363K 0.17% 231

Other funds holding TTEC

PharVision Advisers's TTEC Position: Q2 2026 in Review

PharVision Advisers reduced its TTEC Holdings (TTEC) stake by 51% in Q2 2026, selling an estimated $37.4K and leaving 14,117 shares worth $27.4K. The position accounts for 0.52% of the portfolio, ranked #62.

PharVision Advisers first reported a position in TTEC in Q3 2025 and has held it in 3 quarters since. The position peaked at $297K in Q3 2025. 84 funds tracked by Wall St. Rank hold TTEC as of Q2 2026.

  • PharVision Advisers held 14,117 shares of TTEC Holdings worth $27.4K as of Q2 2026.
  • PharVision Advisers sold 14,457 TTEC Holdings shares in Q2 2026, an estimated $37.4K.
  • TTEC Holdings made up 0.52% of PharVision Advisers's portfolio in Q2 2026, its #62 holding.
  • PharVision Advisers first reported a position in TTEC Holdings in Q3 2025 and has held it in 3 quarters since.
  • PharVision Advisers's TTEC Holdings position peaked at $297K in Q3 2025.
  • 84 funds tracked by Wall St. Rank held TTEC Holdings as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.